However, this protective mechanism is disrupted in cancer-immunity cycle, where the overexpressed PD-L1 binds to PD-1, inhibits the activation of T cell including through induction of T cell apoptosis, thereby inhibiting the anti-cancer immunity [10]. Here, CD274 is linked to cancer.